On March 6, BGI and Nanjing Novaeda Biotech Co., Ltd. ("Novaeda") officially signed a cooperation agreement. The two parties will focus on the fields of life sciences and in vitro diagnostics, aiming to jointly promote technological innovation and product application through complementary advantages, inject new impetus into the development of brain science and brain health, and create a new paradigm for the coordinated development of China's biotechnology.